PARP1 and osteosarcoma: Overexpression of miR-96 decreased the efficiency of HRR and enhanced the sensitivity of osteosarcoma cells to the PARP inhibitor, AZD2281, and cisplatin, indicating that miR-96 regulates DNA repair and chemosensitivity by repressing RAD51 [120].